Zhang P, Lavoie PM, Lacaze-Masmonteil T, Rhainds M, Marc I. (2014) Pediatrics. peds.2014-0459. [Epub ahead of print]
BACKGROUND AND OBJECTIVE:
Omega-3 long chain polyunsaturated fatty acid (LCPUFA) exposure can be associated with reduced neonatal morbidities. We systematically review the evidence for the benefits of omega-3 LCPUFAs for reducing neonatal morbidities in extremely preterm infants.
METHODS:
Data sources were PubMed, Embase, Center for Reviews and Dissemination, and the Cochrane Register of Controlled Trials. Original studies were selected that included infants born at
CONCLUSIONS:
Large-scale interventional studies are required to determine the clinical benefits of omega-3 LCPUFA, specifically in extremely preterm infants, during the neonatal period.
Copyright © 2014 by the American Academy of Pediatrics.